Engineering Medicines To Improve Patient Care

About Viridian

Viridian Therapeutics is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases. Viridian’s expertise in antibody discovery and engineering enables it to develop differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas.

Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The Company recently initiated its first global Phase 3 trial called ‘THRIVE’ to evaluate the safety and efficacy of VRDN-001 in patients with active TED. Viridian is also evaluating VRDN-001 in a Phase 2 proof-of-concept trial in patients with chronic TED. In addition to its intravenously administered VRDN-001 program, the Company is advancing two candidates for its subcutaneous strategy with the goal of providing a more conveniently administered therapy to patients with TED. Viridian is developing multiple preclinical assets in autoimmune and rare diseases.

Leadership

Scott Myers

Scott Myers

President and Chief Executive Officer

Read Bio >
Barrett Katz

Barrett Katz, M.D., M.B.A.

Chief Medical Officer

Read Bio >
Tony Casciano

Tony Casciano

Chief Commercial Officer

Read Bio >

Deepa Rajagopalan, M.D.

Chief Product and Strategy Officer

Read Bio >
Rob Henderson

Rob Henderson, Ph.D.

Chief Scientific Officer

Read Bio >
Seth Harmon

Seth Harmon

Senior Vice President of Finance and Accounting

Read Bio >
Janielle Newland

Janielle Newland

Chief Administrative Officer

Read Bio >
Lara Meisner

Lara Meisner

Chief Legal Officer

Read Bio >
Thomas Ciulla

Thomas Ciulla, M.D., M.B.A.

Chief Development Officer

Read Bio >
Vahe Bedian

Vahe Bedian, Ph.D.

Co-Founder and Scientific Advisor

Read Bio >
Todd James

Todd James

SVP, Corporate Affairs and Investor Relations

Read Bio >

Board of Directors

Arlene Morris

Arlene Morris

Chief Executive Officer, Willow Advisors

Read Bio >
Peter Harwin

Peter Harwin

Managing Member, Fairmount Funds Management LLC

Read Bio >
Tomas Kiselak

Tomas Kiselak

Managing Member, Fairmount Funds Management LLC

Read Bio >
Jennifer Moses

Jennifer Moses

Chief Financial Officer, Investors Management Corporation

Read Bio >
Scott Myers

Scott Myers

President and Chief Executive Officer

Read Bio >